Open AccessEntecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
Author(s) -
S Brost,
Paul Schnitzler,
Wolfgang Stremmel,
Christoph Eisenbach
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i43.5447
Subject(s) - entecavir , medicine , hbsag , immunosuppression , hepatitis b , seroconversion , hepatitis b virus , gastroenterology , immunology , lamivudine , antibody , virus
To study the efficacy and safety of entecavir (ETV) as first-line therapy for hepatitis B virus (HBV) reactivation due to immunosuppression.